Navigation Links
Project could save the eyesight of thousands
Date:10/31/2013

Scientists from the University of Sheffield have partnered with a team in India for a project which could save the eyesight of thousands of people living in the South Asian country.

As in most developing countries, corneal infection in India is a serious problem and many patients are diagnosed too late to save their vision.

The University of Sheffield has received funding from the Wellcome Trust to work with the LV Prasad Eye Institute, in Hyderabad, to develop a new, easy to use technology that will aid in rapid diagnosis and rapid treatment to reduce the number of patients losing their eyesight.

Professor Steve Rimmer, from the University's Department of Chemistry, is leading the Sheffield team. He said: "We are attacking a major problem in India, especially rural India and if successfully introduced into practise we might save the eyesight of thousands of patients."

Along with his colleagues; Professor Ian Douglas, from the University's School of Clinical Dentistry and Professor Sheila MacNeil, from the Department of Materials Science and Engineering, the trio have designed polymers which - on recognition of bacteria - collapse around it trapping the bacteria in place and then allowing it to be removed. The process has been used on eyes allowing bacteria to be removed from the cornea.

Corneal infection is either caused by bacteria or fungi. The new research will now extend the group's work to also recognise fungi. It will work by adding dyes which change colour depending on what is causing the infection so doctors know what treatment to prescribe.

Professor Rimmer added: "Thousands of patients lose their eyes because of late diagnosis in India and the developing world.

"The issues are especially acute in rural areas where access to primary eye care is limited. Lack of facilities also means that when treatment is commenced early clinicians are forced to simply use multiple mixtures of drugs, such as antibiotics and of course this increases the rate at which pathogens develop resistance.

"Once fully developed our system should provide a cost-effective and rapid way of identifying the two classes of bacterial infection or fungal infections.

"The system can be applied without laboratory facilities and results would be obtained within an hour, allowing medical staff to quickly provide the right therapy in the field."

The clinical lead for the project is Dr Prashant Garg, associate director of LV Prasad Eye Institute. The institute is internationally recognised for its pioneering work across many aspects of eye disease and blindness and treats 1,200 new corneal infections every year.

It is hoped the three year project will ultimately lead to a huge reduction in patients losing their eyesight.

This is the second Wellcome funded Affordable Healthcare project for the University of Sheffield with LV Prasad. The first, led by Professor Sheila MacNeil in the UK and Dr Virender Sangwan in India, is developing a biodegradable synthetic membrane for the delivery of stem cell therapy to the eyes of patients who are blinded by damage to the cornea as a result of chemical injury or burns.


'/>"/>

Contact: Clare Parkin
clare.parkin@sheffield.ac.uk
01-142-229-851
University of Sheffield
Source:Eurekalert

Related medicine news :

1. Thyroid project sheds light on molecular processes related to cystic fibrosis
2. Pico Projectors Market (Digital Light Processing, Liquid Crystal on Silicon, Laser-Beam-Steering) Worth US$6.08 Billion by 2014 - New Report by MarketsandMarkets
3. Grid Earth Project Receives 2013 Austin Award
4. I-Tech Project Will Turn Out in Lower Costs for the Clinical Research Arena
5. National Robotics Initiative Awards provide $7 million for Carnegie Mellon research projects
6. Mount Sinai Queens Breaks Ground for Expansion Project
7. Gothenburg coordinates EU-project on reducing healthcare costs
8. URC leads new USAID project to improve Haitis health care system
9. The Republic of Tea Announces New Non-GMO Project Verified Teas in Celebration of Non-GMO Month
10. Bcureful® Helps Fund Promising Tuberous Sclerosis Complex Research Project at NYU Langone Medical Center
11. Medorizon Completes Another Meaningful Use Project with Local Physician Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... ... 2012-2016, will keynote Day 2 of the HIMSS Healthcare Security Forum, the nation’s ... the Sheraton Boston Hotel, Sept. 11-13, 2017. , Daniel will deliver his keynote, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare Partners ... their continued efforts to provide innovative offerings to their healthcare partners. These solutions ... build dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding Talent ...
(Date:7/26/2017)... ... ... time to sign up for the new One-A-Month Essential Oil Club for fun and ... Naturals and author of numerous books on essential oils. , , ... , Two items are included in the December mailing. , A ...
(Date:7/26/2017)... Michigan (PRWEB) , ... July 26, 2017 , ... ... appointed Medical Director for the treatment program located in Royal Oak, Michigan. ... of investors who are focused on providing the highest standards in the field of ...
(Date:7/26/2017)... ... 2017 , ... The number of adults 65 years or older is expected ... asthma control in the population are not well described. In a study published in ... journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), researchers identified factors ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... 2017 operating results on Monday, August 7, 2017 after ... 5:00 p.m. ET. ... broadcast of the conference call by dialing 877-201-0168 or ... approximately 15 minutes prior to the call. A live ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/21/2017)... , July 21, 2017 Did you know that ... in 2016? Or that combined spending on brand medicines, generics and ... spending, with brands accounting for just half of this (7 percent)? ... two thirds of the world,s venture capital investments in high-growth biopharmaceutical ... ...
Breaking Medicine Technology: